US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
The 13 style rules that every midlife woman MUST follow (and yes, beige really is banned!)
Shoes are your secret weapon, for ever There's nothing you can't wear on your feet for ever (though2024-05-22Book of Xi's discourses on Chinese modernization published in English, bilingual versions
(Xinhua) 09:02, February 06, 2024BEIJING, Feb. 5 (Xinhua) -- A compilation of excerpts from discours2024-05-22Georgia Steel puts on a VERY busty display in low
Georgia Steel kept it simple and stylish as she arrived at the Grace Jacobs new collection party in2024-05-22Goalie error costs relegation battler Burnley a draw with Brighton in EPL
BURNLEY, England (AP) — A mistake by goalkeeper Aro Muric cost Burnley in a 1-1 draw with Brighton o2024-05-22Red Lobster seeks bankruptcy protection after closing some restaurants
Red Lobster, the casual dining chain that brought seafood to the masses with inventions like popcorn2024-05-22- (Xinhua) 15:16, October 08, 2023BEIJING, Oct. 8 (Xinhua) -- In 1988, when Xi Jinping took office as2024-05-22
atest comment